H.C. Wainwright raised the firm’s price target on Zynex to $21 from $20 and keeps a Buy rating on the shares post the Q4 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZYXI:
- ZYXI Earnings this Week: How Will it Perform?
- Zynex receives FDA clearance for next generation NMES device
Questions or Comments about the article? Write to editor@tipranks.com